VentriJect
VentriJect, a Danish MedTech start-up seeking to revolutionise the way cardiorespiratory fitness (CRF) is measured, has been invited to the United Nations General Assembly (UNGA) in New York to demonstrate Seismofit, its portable VO2 max estimation solution.
It comes after the Innovation Value Institute (IVI) at Maynooth University in the Republic of Ireland selected Seismofit as one of five top digital health solutions helping to drive a radical transformation in healthcare.
The IVI is working towards a transition to a new kind of wellness and health system fuelled and empowered by digital technologies. Judges highlighted Seismofit as a potential digital health ‘game changing solution’ for making healthcare affordable and accessible under its “Stay Left, Shift Left-10X” methodology.
Ventriject says the concept is about using technology to develop preventative approaches that are 10 times more impactful than the current available solution. It proposes that only by using technology can a preventative approach to healthcare become more prevalent globally; reducing the number of people in acute care, thereby minimising the cost of healthcare and maximising patient experience and quality of life.
VentriJect will demonstrate Seismofit to the 4th United Nations General Assembly Digital Health Symposium, being held on 24 – 26th September in New York. The IVI accolade follows winning the second-place award at the Healthcare Innovation World Cup in November 2023 from a pool of over 300 of the most innovative global healthcare start-ups.
Seismofit enables CRF to be estimated without the need for exercise and in less than three minutes using an advanced algorithm together with a technology called seismocardiography. This provides a clinically validated way to estimate VO2 max, which is an indicator of CRF. According to the company, there is 'sigificant' published evidence that CRF is one of the best indicators of health and has a strong correlation with other health indicators and mortality.
VO2 max is usually measured through a Cardiopulmonary Exercise Test (CPET) test. However, this technique can take over 20 minutes to conduct, and requires specialist staff and exercise until exhaustion, making it unpleasant for most and unsuitable for the elderly or those with an injury or disability. VentriJect’s device eliminates the need for this by recording chest wall vibrations caused by the beating heart and uses an AI assisted algorithm to accurately estimate VO2 max.
The company has been focused on using technology, combined with a preventative approach to healthcare, to improve patient outcomes. This has become especially important as healthcare systems have come under increasing pressure from strained resources and ageing populations across the globe says Ventriject.
“We are on a mission to help transform global health and wellbeing, so it’s great to have been provided the most prestigious platform of all to do so, the United Nations,” said Mikkel Kristiansen, CEO at VentriJect.
"We’re delighted that the IVI has recognised the importance of making the measurement of CRF accessible to all and the potential our technology has to shift from acute care to preventative care. We can’t wait to showcase it in New York.”
